That
same year Deirdre joined
Lilly as a sales representative and started her upward trajectory in the
pharmaceutical corporate world. She moved to San Juan a year later in 1984 as a
marketing associate. Deirdre then progressed through higher positions in the
sales and marketing area. In 1995, she became general manager for Eli Lilly
Puerto Rico, SA.
More
promotions followed then in 2005 Deirdre became the President of US operations.
This was a high point in her career but it was just the beginning of a new
chapter. GlaxoSmithKline (GSK) was interested in her and she joined the company
in February 2009 as President, North America Pharmaceuticals. This was a huge responsibility given that GSK
is a British multinational company. She is basically the right-hand person in
the U.S. to GSK’s CEO.
While
Deirdre is the first woman to hold the position she does not feel any
discomfort and believes there will even be more diversity (including
nationality) at GSK given its own diverse customers.
Recently
GSK bought Human Genome Sciences for $3.6 billion. Using human genome data to
help produce curing drugs has always been a challenging yet potentially
rewarding combination. Deirdre has been appointed
as president and CEO to lead this company.
No comments:
Post a Comment